Skip to product information
1 of 1

Siglec-2/CD22 His Tag Protein, Rat

Siglec-2/CD22 His Tag Protein, Rat

Catalog Number: UA010979 Reactivity: Rat Conjugation: Unconjugated Brand: UA BIOSCIENCE
Price:
Regular price $236 USD
Regular price Sale price $236 USD
Size:
For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Species Rat
Synonyms Siglec-2, CD22, BL-CAM, B-cell receptor CD22
Accession D3ZD88
Amino Acid Sequence

Trp24-Arg692 with His Tag at C-Terminus

Expression System HEK293
Molecular Weight

95-120kDa (Reducing)

Purity >95% by SDS-PAGE & SEC-HPLC
Endotoxin <0.1EU/μg
Conjugation Unconjugated
Tag His Tag
Physical Appearance Lyophilized Powder
Storage Buffer PBS, PH7.4, 5% trehalose
Reconstitution

Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.

Stability & Storage · 12 months from date of receipt, lyophilized powder stored at -20 to -80℃.
· 3 months, -20 to -80℃ under sterile conditions after reconstitution.
· 1 week, 2 to 8℃ under sterile conditions after reconstitution.
· Please avoid repeated freeze-thaw cycles.
Reference

1、Tedder T F. et al. (2005) CD22: a multifunctional receptor that regulates B lymphocyte survival and signal transduction. Adv Immunol. 88: 1-50.
2、Fujimoto M. et al. (2007) B cell signaling and autoimmune diseases: CD19/CD22 loop as a B cell signaling device to regulate the balance of autoimmunity. J Dermatol Sci. 46(1): 1-9.
3、Walker J A. et al. (2008) CD22: an inhibitory enigma. Immunology. 123(3): 314-325.
4、Nitschke L. (2009) CD22 and Siglec-G: B-cell inhibitory receptors with distinct functions. Immunol Rev. 230(1): 128-143.

Background

Siglec-2, also known as CD22, is a member of the immune inhibitory Siglecs family, which carries ITIM motifs to transmit immunosuppressive signals. These signals result in reduced phagocytosis, diminished inflammation, and inhibition of danger-associated molecular pattern (DAMP)/pathogen-associated molecular pattern (PAMP)-mediated inflammation.
Siglec-2 is a cell surface receptor predominantly expressed on B cells, where it regulates B-cell proliferation, survival, signaling, and antibody production. The cytoplasmic tail of Siglec-2 contains six tyrosine residues, four of which are located within ITIM motifs: Y783, Y843, Y863, and Y828. Upon cross-linking of B-cell receptors (BCRs), these tyrosine residues become phosphorylated, recruiting Src homology region 2 (SH2) domain-containing protein tyrosine phosphatase-1 (SHP-1). This recruitment leads to the dephosphorylation of BCR-proximal signaling complexes.
Given its unique presence on B lymphocytes, Siglec-2 is an attractive therapeutic target. Currently, there are numerous ongoing trials assessing the safety and efficacy of CD22-directed chimeric antigen receptor (CAR) therapies, particularly in children with relapsed or refractory B-cell leukemia. Additionally, the development of novel CARs, such as bispecific CD20/CD22 CARs and CD19/CD22 CARs, is underway.

Picture

SDS-PAGE

1μg (R: reducing condition, N: non-reducing condition).

SEC-HPLC

The purity of Siglec-2/CD22 His Tag Protein, Rat is more than 95% determined by SEC-HPLC.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)